Table 1 Number of days with completed electronic diary evening reports, by population and time period
Population | Eptinezumab | Placebo | ||
|---|---|---|---|---|
Baseline | Weeks 1–24 | Baseline | Weeks 1–24 | |
CM, N = 1072 (eptinezumab, n = 706; placebo n = 366) | 18,504 | 100,390 | 9560 | 50,632 |
CM + MOH, N = 431 (eptinezumab, n = 286; placebo n = 145) | 7500 | 41,113 | 3805 | 20,423 |
CM + MOH + ≥50% response, N = 225 (eptinezumab, n = 176; placebo, n = 49) | 4652 | 25,855 | 1263 | 6850 |